Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
105 participants
INTERVENTIONAL
2014-01-01
2018-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Foetuses, newborns, infants and children that are referred for autopsy at three different institutions associated with the University of Zurich will be eligible for recruitment. All bodies will be examined with a commercial CT and a 3 Tesla MRI scanner, and investigators will be blinded to the results of conventional autopsy. After cross-sectional imaging, CT-guided tissue sampling will be performed by a multifunctional robotic system (Virtobot) allowing for automated post-mortem biopsies. Virtual autopsy results will be classified with regards to the likely final diagnosis and major pathological findings and compared to the results of conventional autopsy, which remains the diagnostic gold standard.
This interdisciplinary study will determine whether virtual autopsy will narrow the gap in information between non-invasive and traditional autopsy procedures.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Magnetic Resonance Imaging Autopsy Study
NCT01417962
Imaging Modalities in Diagnosing Necrotizing Enterocolitis in Preterm Infants.
NCT03188380
The Effect of Bedside Ultrasound Assistance on the Proportion of Successful Infant Spinal Taps
NCT02133066
Repeat Lumbar Puncture at 24 Versus 48 Hours After Traumatic Lumbar Puncture in Neonates
NCT04794881
Modern Ultrasound Techniques in the Evaluation of Cerebral Venous Sinuses in Neonates
NCT00555932
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
CROSSOVER
DIAGNOSTIC
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Foetuses
* still birth and termination of pregnancies
* intervention: minimally invasive, virtual autopsy
Minimally invasive, virtual autopsy
Post-mortem cross-sectional imaging with CT-guided biopsy
Conventional autopsy
Newborns
* who died of natural- and non-natural cause
* intervention: minimally invasive, virtual autopsy
Minimally invasive, virtual autopsy
Post-mortem cross-sectional imaging with CT-guided biopsy
Conventional autopsy
Children and adolescents
* who died of natural- and non-natural cause
* intervention: minimally invasive, virtual autopsy
Minimally invasive, virtual autopsy
Post-mortem cross-sectional imaging with CT-guided biopsy
Conventional autopsy
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Minimally invasive, virtual autopsy
Post-mortem cross-sectional imaging with CT-guided biopsy
Conventional autopsy
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Live born infants ≥ 16 0/7 weeks GA until adolescents up to 16 years of age, who died of natural- and non-natural cause (trauma, homicide, suicide and intoxication).
Exclusion Criteria
* Lack of parental consent
16 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Zurich
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Hans Ulrich Bucher, MD, Prof
Role: STUDY_DIRECTOR
University Hospital Zurich, Division of Neonatology
Christoph Rüegger, MD
Role: PRINCIPAL_INVESTIGATOR
University Hospital Zurich, Division of Neonatology
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University Hospital Zurich, Division of Neonatology
Zurich, Canton of Zurich, Switzerland
Division of obstetrics, University Hospital Zurich
Zurich, , Switzerland
University Children's Hospital Zurich
Zurich, , Switzerland
Zurich Institute for Forensic Medicine
Zurich, , Switzerland
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Ruegger CM, Gascho D, Bode PK, Bruder E, Haslinger C, Ross S, Schmid K, Knopfli C, Hofer LJ, Held L, Martinez RM, Bucher HU; Virtopsy Study Group. Post-mortem magnetic resonance imaging with computed tomography-guided biopsy for foetuses and infants: a prospective, multicentre, cross-sectional study. BMC Pediatr. 2022 Aug 3;22(1):464. doi: 10.1186/s12887-022-03519-4.
Ruegger CM, Bartsch C, Martinez RM, Ross S, Bolliger SA, Koller B, Held L, Bruder E, Bode PK, Caduff R, Frey B, Schaffer L, Bucher HU. Minimally invasive, imaging guided virtual autopsy compared to conventional autopsy in foetal, newborn and infant cases: study protocol for the paediatric virtual autopsy trial. BMC Pediatr. 2014 Jan 20;14:15. doi: 10.1186/1471-2431-14-15.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Paediatric virtopsy
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.